A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

Completed · Phase 3

Conditions studied: Open-angle Glaucoma, Ocular Hypertension

In brief

The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT00465803

Run by

Alcon Research

People needed

81

Starts

2007-03-01

Last updated by the study team

2014-07-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients with open-angle glaucoma or ocular hypertension;
• Other protocol-defined inclusion criteria may apply.

You may not qualify if…

• Visual acuity worse than 0.60;
• Other protocol-defined exclusion criteria may apply.

Where it is running

• Seattle — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.